Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
All-cause mortality
[34] Systematic review	5201 people 8 RCTs in this analysis	Rate of mortality 331/2889 (11%) with angiotensin II receptor blockers (ARBs) 295/2312 (13%) with ACE inhibitors	OR 1.06 95% CI 0.90 to 1.26		Not significant
[35] Systematic review	4310 people 3 RCTs in this analysis	Rate of mortality 317/2257 (14.0%) with ARBs 286/2053 (13.9%) with ACE inhibitors	RR 1.06 95% CI 0.56 to 1.62		Not significant